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Sensitivity and specificity of the ankle–brachial 
index to diagnose peripheral artery disease: 
a structured review
Dachun Xu1,2, Jue Li1,3, Liling Zou1, Yawei Xu1,2, Dayi Hu1,
Sherry L Pagoto4 and Yunsheng Ma4
Abstract
The ankle–brachial index (ABI) is a simple, inexpensive diagnostic test for peripheral artery disease (PAD). However, 
it has shown variable accuracy for identification of significant stenosis. The authors performed a structured review of 
the sensitivity and specificity of ABI ≤ 0.90 for the diagnosis of PAD. MEDLINE, EMBASE, Cochrane databases, Science 
Citation Index database, and Biological Abstracts database were searched for studies of the sensitivity and specificity of 
using ABI ≤ 0.90 for the diagnosis of PAD. Eight studies comprising 2043 patients (or limbs) met the inclusion criteria. 
The result indicated that, although strict inclusion criteria on studies were formulated, different reference standards were 
found in these studies, and methods of ABI determination and characteristics of populations varied greatly.  A high level 
of specificity (83.3–99.0%) and accuracy (72.1–89.2%) was reported for an ABI ≤ 0.90 in detecting ≥ 50% stenosis, but 
there were different levels of sensitivity (15–79%). Sensitivity was low, especially in elderly individuals and patients with 
diabetes. In conclusion, the test of ABI ≤ 0.90 can be a simple and useful tool to identify PAD with serious stenosis, and 
may be substituted for other non-invasive tests in clinical practice.
Keywords
accuracy; ankle–brachial index; peripheral artery disease; sensitivity; specificity
Introduction
Peripheral artery disease (PAD) is a clinical manifestation 
of the atherosclerotic process. Individuals with PAD have a 
three- to fourfold increased risk of cardiovascular disease 
(CVD) morbidity and mortality compared to individuals 
without PAD. Using the ankle–brachial index (ABI) ≤ 0.90, 
at least 6.8 million Americans (5.8%) aged 40 years or 
older had PAD in 2000,1 which was different from other 
studies.2–4 The age-adjusted prevalence of PAD was 12% 
when ABI was used to diagnose PAD in older adults.2 An 
arteriography has been considered a gold standard for 
assessing PAD severity, location, and extent.5 However, the 
general use of arteriography is limited because of the use of 
ionizing radiation and also because of the risk of local and 
systemic complications arising from the invasive nature of 
the procedure and the use of nephrotoxic contrast media. 
Consequently, several non-invasive tests have been designed 
for the detection of PAD in clinical practice. These tests 
include digital subtraction angiography (DSA), computed 
tomography angiography (CTA), whole body magnetic reso-
nance angiography (WBMRA), Doppler waveform analysis 
(DWA), color duplex ultrasound (CDU), color duplex imag-
ing (CDI) and ABI. Among these tests, the ABI is the most 
simple and inexpensive test.6 Among well-trained techni-
cians, its reliability has been excellent, and the validity of the 
test for stenosis of ≥ 50% in leg arteries is high (sensitivity ≈ 
90% and specificity ≈ 98%).7
However, different methods have existed for ABI calcu-
lation, and different cutoff values of ABI have been used 
in the literature. Although an ABI ≤ 0.90 has been recom-
mended by the American Heart Association (AHA),8 
whether the higher or lower of the two ankle arterial systolic 
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pressures should be used was not specified, and there has 
been some disagreement in the literature regarding the 
measurement of ABI.9 The higher, the lower, or sometimes 
the average systolic blood pressures of the dorsal pedal and 
posterior tibial arteries within the legs have been used to 
calculate the ABI.10 Importantly, the ABI was not compared 
side-by-side with results from arteriography in many stud-
ies, thus limiting accurate evaluation of the data.
The accuracy of ABI has been the primary focus of a 
number of studies on PAD, but to date there has been no 
structured review of these studies. Thus, the primary objec-
tive of the present study is to conduct a structured review to 
determine the accuracy of the ABI as a diagnostic tool to 
detect significant stenosis (≥ 50%) in PAD.
Methods
Search	strategy	and	selection	criteria
A structured review of original articles analyzing the sensi-
tivity and specificity of ABI for the diagnosis of PAD was 
performed by searching MEDLINE (January 1966 to 
December 2008), EMBASE (January 1980 to December 
2008), Web of Science – Science Citation Index database, 
the Cochrane Library and Biological Abstracts database 
(January 1969 to December 2008).
Although DSA is considered the best method for assess-
ing PAD severity, location, and extent;5 some studies have 
shown that WBMRA has good accuracy for grading stenosis 
with DSA as reference;11–13 DWA was also a non-invasive 
method widely used to diagnose PAD;14,15 moreover, there 
was excellent agreement between arteriography and CDU 
findings (the coefficient of correlation was 0.95).16 Non-
invasive and easy methods of detecting PAD were preferred 
in clinical practice, so an imaging diagnostic technology 
was often used in many of the studies as a standard reference 
in defining serious luminal stenosis for the diagnosis of 
PAD. Studies were eligible if the sensitivity and specificity 
of ABI ≤ 0.90 for stenosis ≥ 50% in peripheral arteries were 
clearly reported by comparison with a standard reference 
such as DSA,17,18 WBMRA,19 DWA,20 CDI,21 CDU,16,22 
and arteriography.23 Additionally, relevant references cited 
within identified publications were reviewed.
The search strategy included the following keywords in 
various combinations: “ankle brachial index”, “ankle arm 
index”, “peripheral arterial disease”, “peripheral arterial 
occlusive disease”, “peripheral vascular disease”, “lower 
extremity arterial disease”, “sensitivity”, “specificity”, and 
“accuracy”.
The titles and abstracts of articles retrieved by this search 
strategy were evaluated against inclusion criteria, and the 
studies deemed potentially eligible were obtained by requests 
to authors. When overlapping or duplicate data sets were 
detected on the same series of patients, only the most recent 
or most informative study was included in the analysis.
Data	extraction
Two investigators independently extracted data from 
selected articles, which included year of publication, first 
authors, patient demographics, study objective, study inclu-
sion and exclusion criteria, reported sensitivity and specifi-
city of ABI in PAD and summary statistics on ABI cases, if 
available. Studies were initially selected according to the 
following criteria: (i) language: English full text articles; 
(ii) accuracy of ABI for diagnosis of PAD: based on a refer-
ence standard; (iii) study design: cross-sectional or com-
parative study; and (iv) sample size: at least 50 participants.
Quality	assessment
Reporting of a total of seven items was evaluated: (i) the 
study had a clearly stated aim; (ii) consecutive patients 
were included; (iii) an appropriate reference standard was 
used; (iv) a prospective calculation of sample size was 
reported; (v) a cutoff ABI value was 0.90; (vi) a threshold 
value of stenosis for PAD was 50%; and (vii) actual num-
bers of true positive, true negative, false positive and false 
negative results of the tests or predicted positive and nega-
tive values were reported.
Results
The initial search resulted in 256 articles. The title and 
abstract of each retrieved publication were reviewed to 
confirm that the sensitivity and specificity of ABI ≤ 0.90 
for stenosis was ≥ 50% in peripheral arteries and that 
results were compared with a standard reference such as 
arteriography, DSA, CTA, WBMRA, DWA, CDI, or 
CDU. In the event that this information could not be 
determined from the abstract, the full article was 
retrieved and further reviewed. This process resulted in 
the selection of 33 studies. Of these, 25 articles were 
further excluded from this analysis: two used a stetho-
scope and an auscultatory method to determine ABI, 
respectively;24,25 one used an automatic blood pressure 
device to determine ABI;26 one determined ABI at exer-
cise;27 two used tissue oxygen saturation and pedal pulse 
palpation to determine PAD, respectively;28,29 two used 
ABI < 0.80 and 1.0 for PAD, respectively;30,31 one used 
ABI < 0.90 for the detection of arterial lesions in 
extremities;32 one used ABI > 1.3 for PAD;33 one 
included patients with stenosis > 70% in leg arteries;34 
10 articles did not use an appropriate reference standard 
for PAD;35–44 one paper had a sample size of only 39 
patients;45 and three were review articles.46–48 Figure 1 
shows the study selection process. Table 1 provides the 
overall characteristics of 22 excluded articles (not 
including the three review articles).
Eight studies meeting the inclusion criteria reported on a 
total of 2043 patients (or limbs): some studies used the 
number of patients as variables for identification of signifi-
cant stenosis, whereas others used the number of limbs. 
Table 2 presents characteristics of the studies selected. Of 
these, all (100%) underwent a reference test except in one 
study,23 where angiograms were available for 53 of these 
patients. There were some differences in ABI methodology 
in eight papers.
Because PAD is associated with age, smoking status, 
type 2 diabetes, hypertension, and dyslipidemia, baseline 
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measures of these variables are obtained through corre-
sponding authors. Table 3 presents baseline demographic 
characteristics of these patients. A total of 786 limbs were 
from women and 807 limbs were from men. Age was 
reported in the studies and ranged from 35 to 94 years old. 
Table 4 provides detailed data on positive, negative, sensi-
tivity, specificity, accuracy and other selected characteris-
tics. Sensitivity ranged from 15.0% to 79.0%, whereas 
specificity and accuracy ranged from 83.3% to 99.0% and 
72.1% to 89.2%, respectively.
Discussion
The present study represents the first structured review 
focusing on ABI for the diagnosis of PAD, and indicates 
that an ABI ≤ 0.90 has a perfect specificity and high accu-
racy, but its sensitivity varied widely and is lower than the 
approximately 90% sensitivity reported in previous arti-
cles.7,28,49–51 Furthermore, many imperfect diagnostic meth-
ods were found in the studies when compared with the ABI 
test as standard references, and different methods have 
existed for ABI calculation in the literature. In addition, 
eight studies differed in international scope, populations, 
design, and clinical settings.
According to recent guidelines for the Detection, 
Evaluation and Treatment of High Blood Cholesterol in 
Adults (Adult Treatment Panel III), the ABI should be con-
sidered for patients with PAD who have adverse prognostic 
features. Both the American Heart Association and 
American Diabetes Association recommend annual screen-
ing for lower extremity arterial disease (LEAD) in patients 
with type 2 diabetes and those aged over 40 years old.52 We 
also found that the test of ABI ≤ 0.90 has an excellent spe-
cificity (83.3–99.0%) and high accuracy (72.1–89.2%) in 
these studies.
However, the sensitivity of the ABI test varied widely 
among these published studies.
ABI detection in type 2 diabetes and the elderly yielded 
lower sensitivity, 15–20%,19 63%,20 68%,16 69.3%17 and 
70.6%,22 suggesting that the test may be affected by diabe-
tes status and aging. Many elements may contribute to the 
sensitivity of ABI detection, including patients’ age, ethnic-
ity, and health status, as well as other factors. Our review 
includes patients with a wide age range (35–94 years old), 
and thus arterial wall calcinosis in elderly individuals might 
have led to overestimation of artery pressure. Additionally, 
both genetic and environmental factors may lead to a lower 
ABI and greater prevalence of PAD in African Americans,53 
who had approximately 1.5 times as much aortic surface 
involvement of fatty streaks as did non-Hispanic white 
individuals.54 However, the difference in ABI is trivial in 
that Aboyans et al. reported an ABI 0.02 difference between 
citations excluded after initial screening: 223
articles excluded = 25
reason for exclusion:
• two used a stethoscope and an auscultatory method to 
determine ABI, respectively;
• one used an automatic blood pressure device to 
determine ABI; 
two used a tissue oxygen saturation and pedal pulse
palpation to determine PAD, respectively;
•
•
one determined ABI at exercise;
• two used ABI <0.80 and 1.0 for PAD, respectively;
• one used ABI <0.90 for the detection of arterial lesions 
in extremities;
• one used ABI >1.3 for PAD;
• one included patients with stenosis >70% in leg arteries;
• 10 did not use an appropriate reference standard for 
PAD;
• one paper had a sample size of only 39 patients;
• three were review articles.
8 articles included in the review of ABI tests for PAD
256 potentially relevant citations (titles/abstracts) identified all searches
33 studies selected for full-text
Figure 1. Study selection process and reasons for exclusion.
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African Americans and non-Hispanic white individuals.55 
Furthermore, arterial wall calcinosis in diabetes might lead 
to an overestimation of the lower limb pressure which leads 
to a low sensitivity. This may be attributable to increased 
incidence of arterial calcification, which can cause 
increased vascular rigidity and spuriously elevate the ABI 
in diabetes and in elderly individuals. Moreover, the reason 
for elevated ABI values in spite of stenosis could be due to 
collateral circulation, which maintains blood flow to the 
lower limb beyond the obstruction.
Wikstrom et al.19 reported a poor sensitivity of 20% 
(right leg) and 15% (left leg) on the ABI test. We carefully 
reviewed this study. In addition to arterial wall calcinosis in 
elderly individuals (average age was 76 years in this study), 
WBMRA used in this study had a lower spatial resolution 
which could result in over- and under-grading of stenosis, 
especially on the smaller caliber vessels of the lower legs. 
Furthermore, the ABI was calculated for each leg by only 
posterior tibial artery pressure with the brachial artery pres-
sure, which was measured unilaterally by a mercury sphyg-
momanometer instead of the Doppler method. Moreover, 
the study was imperfect because of the interval (range 
3–24 months) between the ABI and WBMRA test; the 
development of stenosis in some cases during this time 
frame could not be excluded. All these could contribute to 
a low sensitivity of ABI for stenosis detection in this study.
The previous articles stated that the ABI test had a sen-
sitivity of > 90% and a specificity of > 95% in diagnosing 
> 50% stenosis of lower limb arteries. We carefully 
reviewed these studies and found important differences, 
which include the following: (i) the populations in these 
studies were composed of surgical patients and young 
healthy controls,7,49,50 whereas most of patients had cardio-
vascular risk factors in our review such as being older, 
smoking, and having diabetes, hypertension and dyslipi-
demia; (ii) Ouriel et al.7 used ABI < 0.97 for diagnosis of 
PAD and failed to describe the diseased limbs included in 
their analysis; (iii) Yao et al.,49 Criqui et al.50 and Carter
et al.51 reported that the ABI was a sensitive test for PAD, 
but did not report any sensitivity or specificity for the 
ABI and included less than 50% stenosis in their analy-
sis;49,50 (iv) Feigelson et al.30 reported that a combination of 
ABI ≤ 0.8 and a posterior tibial peak forward flow ≤ 3 cm/s 
had a sensitivity of 89% and a specificity of 95% in diag-
nosing PAD.
The ABI is performed by measuring the systolic blood 
pressure from both brachial arteries and from the dorsal 
pedal (DP) or posterior tibial (PT) arteries after the patient 
has been at rest in the supine position for 10 minutes. 
Optimal recordings are obtained with blood pressure cuffs 
that are appropriately sized to the patient’s lower calf 
(immediately above the ankle), and systolic pressures are 
recorded with a handheld Doppler instrument16,17,19,20–23 or 
oscillometric method.18 Since ankle arterial pressures are 
normally greater than 90% of the brachial arterial pressure, 
an ABI ≤ 0.90 has been used in the diagnosis of PAD.2,18,23 
Nevertheless, the three most common methods were used 
to calculate the ABI: HAP-ABI = higher of DP and PT/
higher of the two brachial systolic pressures; LAP-ABI = 
lower of DP and PT/higher of the two brachial systolic 
pressures; ABI = mean of DP and PT/mean of both 
arms.16,17,56 Furthermore, Tables 1, 2 and 4 show that other 
methods were also used, which led to different sensitivity 
and specificity, as well as prevalence of PAD.10 The LAP-
ABI method was superior to HAP-ABI in sensitivity within 
each leg, which studied significant stenosis of limbs instead 
of patients.16,17 The authors confused the lower of the two 
ipsilateral ankle pressures with the lower of the right and 
left leg ABIs; the LAP-ABI method was more sensitive 
(83.7%,17 89%16 vs 69.3%,17 68%16), but with a less specific 
and positive predictive value than HAP-ABI (64.3%17, 
93%16 vs 83.3%17, 99%16).
Table 3. Baseline characteristics and medical conditions
Variables Value or frequency 
(statistical estimate)
Age, years  35–94
Men, n (%)  807 (50.7)
Diabetes, n (%)  570 (35.8)
Dyslipidemia, n (%)  982 (61.6)
Hypertension, n (%) 1142 (71.7)
Smoking history, n (%)  415 (26.1)
Table 4. Performance of ABI ≤ 0.90 in detecting ≥ 50% stenosis in PAD
First author Tp Fp Fn Tn Se Sp +Pv –Pv A n
Schroder16  77  1 36 102 68.0 99.0 99.0 74.0 82.9 216
Niazi17 115  7 51  35 69.3 83.3 94.3 40.7 72.1 208
Guo18  16 28  5 249 76.0 90.0 36.4 98.0 88.9 298
Wikstrom (right leg)19  10  2 41 215 20.0 99.0 83.0 84.0 84.0 268
Wikstrom (left leg)19   9  2 52 202 15.0 99.0 82.0 80.0 79.6 265
Parameswaran20  22  2 13  77 63.0 97.0 91.7 85.6 86.8 114
Williams21  28  5  9  88 76.0 95.0 84.8 90.7 89.2 130
Premalatha22  48  3 20  23 70.6 88.5 94.1 53.5 75.5  94
Lijmer23  63  1 17  13 79 96 98.4 43.3 80.9  94
Tp, true positive; Fp, false positive; Fn, false negative; Tn, true negative; Se, sensitivity; Sp, specificity; +Pv, positive predictive value; –Pv, negative 
predictive value; A, accuracy.
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An important theme that emerges from these studies is 
imperfect diagnostic accuracy of these imaging diagnostic 
techniques such as WBMRA, CDI, DWA and CDU, which 
preclude a formal meta-analysis. Therefore, blood pressure 
has been similarly affected by physical and psychological 
conditions, the Doppler device, setting circumstances, and 
technicians’ experience. All these lead to variance in accu-
racy of the ABI test.
A true quantitative meta-analysis is not possible because 
of the variety in study designs, populations and methods of 
ABI. Moreover, the comparison of a diagnostic test against 
imperfect standard references may result in underestima-
tion of the test accuracy. Therefore, a limitation of the 
present review is that it constituted a qualitative analysis 
and hence could be considered a subjective appraisal. We 
chose to include a varied selection of studies to provide a 
perspective as balanced as possible. The studies originated 
in many different countries and were conducted by differ-
ent sponsors. More studies are needed of the sensitivity and 
specificity of an exact ABI test (≤ 0.90) controlling for as 
many of the variables mentioned above as possible, with a 
well-designed and properly controlled protocol, especially 
by comparison with arteriography in general populations, 
as well as in elderly individuals and in those with diabetes. 
Nevertheless, we believe that some important and consist-
ent messages have emerged that should influence the use of 
ABI in the future.
In conclusion, high specificity and accuracy were 
reported in these articles indicating that ABI ≤ 0.90 could 
reliably identify patients with serious stenosis ≥ 50%. Our 
findings suggest that in populations aged between 40 and 
75 years old with at least one vascular risk factor (i.e. 
hypertension, diabetes, dyslipidemia, tobacco), the ABI 
should be used for a preliminary diagnosis of PAD because 
of its simplicity, convenience, high specificity and high 
degree of accuracy in clinical practice.
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